Lupin informs about press release

23 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding launch of the world’s first fixed-dose triple combination drug under the brand name Vilfuro-G® for the effective management of chronic obstructive pulmonary disease in India. 

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

2061.50 -36.15 (-1.72%)
08-Dec-2025 15:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 924.35
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×